Search Results 731-740 of 17094 for monoclonal antibody
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease ...
Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins. A history or presence of other medical illness that indicates ...
... Monoclonal Antibodies to Treat Hospitalized Patients with COVID-19 Rochester, MN. The purpose of this study is to evaluate the effectiveness, safety, and ...
Herd immunity happens when a sufficient proportion of a population is immune to an infectious disease, meaning spread from person to person is unlikely. So what ...
... monoclonal antibody or kinase inhibitor. Participation in clinical trials ... Use of any neutralizing monoclonal antibodies such as bamlanivimab (LY ...
Monoclonal antibodies: at least 3 half-lives must have elapsed since prior therapy that included a monoclonal antibody; Radiation therapy (RT): >= 2 weeks ...
This system detects heavy metal-labeled antibodies in the time-of-flight chamber of an inductively coupled mass spectrometer (ICP-MS). These capabilities allow ...
Prior monoclonal antibody within 4 weeks prior to study Day 1; Prior Chemotherapy, targeted small molecular therapy, or radiation therapy within 2 weeks ...
... monoclonal antibodies, alpha-4 beta-7 integrin inhibiting monoclonal antibody, interleukin 12/23 inhibiting monoclonal antibody, JAK inhibitors.
Other monoclonal antibodies, antibody-drug conjugates, or radioimmunoconjugates: 4 weeks (2 weeks with documented disease progression);; T-cell or other cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.